SYMBIOTIX BIOTHERAPIES
Symbiotix Biotherapies is a provider of a novel class of molecular therapeutics intended to develop molecules.The company's novel class of molecular therapeutics include a novel class of Treg-modulating therapeutics based on molecules derived from the human microbiom, enabling patients access first-in-class oral agents that improves their lives and helps them to treat themselves of inflammatory bowel disease (IBD), multiple sclerosis (MS) and other serious immune-mediated diseases.
SYMBIOTIX BIOTHERAPIES
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2009-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.symbiotix-bio.com
Total Employee:
11+
Status:
Closed
Contact:
(617) 535-3196
Email Addresses:
[email protected]
Total Funding:
9.3 M USD
Technology used in webpage:
Google Maps IPv6 Cloudflare Hosting GStatic Google Static Content Google Maps API Cloudflare DNS
Similar Organizations
Acuitas Therapeutics
Acuitas provides delivery solutions for molecular therapeutics using lipid nanoparticles (LNP).
Akili Interactive Labs
Akili is a digital therapeutics company that offers Innovative video game-based therapies for neurological and psychiatric conditions.
Cortica
Cortica is a provider of advanced neurological therapies for children with autism and other developmental differences.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Gyros
Gyros is specialized in the production of automated micro-immunoassays for therapeutic protein development.
OptiKira
OptiKira develops novel therapeutics intended to prevent cell death.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Summit Biolabs
Summit Biolabs techniques related to molecular diagnostics intended to detect head and neck cancer recurrence.
Vital Therapies
Vital Therapies is a biotech company focused on developing a cell-based therapy targeting the treatment of acute liver failure.
Current Employees Featured
Founder
Investors List
Kairos Ventures
Kairos Ventures investment in Venture Round - Symbiotix Biotherapies
Official Site Inspections
http://www.symbiotix-bio.com
- Host name: 172.67.170.197
- IP address: 172.67.170.197
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Symbiotix Biotherapies"
Symbiotix Biotherapies - Crunchbase Company Profile …
Contact Email [email protected] Phone Number (617) 535-3196 Symbiotix Biotherapies is a provider of a novel class of molecular therapeutics intended to develop molecules.The company's novel class of molecular therapeutics …See details»
Symbiotix Biotherapies - PitchBook
Symbiotix Biotherapies General Information Description. Developer of a novel class of molecular therapeutics intended to treat inflammatory bowel disease. The company's novel class of molecular therapeutics are oral agents based on …See details»
SYMBIOTIX BIOTHERAPIES, INC. - VentureRadar
" Symbiotix Biotherapies, Inc. is developing a novel class of molecular therapeutics based on molecules derived from the human microbiome. Emerging from over a decade of research at …See details»
Symbiotix Biotherapies Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Symbiotix Biotherapies Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Symbiotix Biotherapies Announces Process Development
Jan 3, 2018 For more information, please visit www.symbiotix-bio.com. About Paragon Bioservices, Inc. Paragon Bioservices is an industry-leading, private-equity backed contract …See details»
Symbiotix Biotherapies - Overview, News & Similar companies
Symbiotix Biotherapies is a provider of a novel class of molecular therapeutics intended to develop molecules.The company's novel class of molecula r therapeutics include a novel class …See details»
Symbiotix Biotherapies Inc - Company Profile and News
Company profile page for Symbiotix Biotherapies Inc including stock price, company news, executives, board members, and contact informationSee details»
Symbiotix Biotherapies - Products, Competitors, Financials, …
Symbiotix Biotherapies’s exclusive license agreement with Harvard University. Apr 13, 2018. Choate recently represented Symbiotix Biotherapies, Inc. (Symbiotix), a pioneering venture …See details»
Symbiotix Biotherapies Announces Process Development
Jan 3, 2018 For more information, please visit www.symbiotix-bio.com. About Paragon Bioservices, Inc. Paragon Bioservices is an industry-leading, private-equity backed contract …See details»
Symbiotix Biotherapies Receives $5 Million in Institutional
Nov 1, 2017 BOSTON--(BUSINESS WIRE)-- Symbiotix Biotherapies, Inc. (“Symbiotix”), a pioneering microbiome company developing novel molecular therapeutics based on the …See details»
Symbiotix Biotherapies Receives $5 Million in Institutional …
Nov 1, 2017 Symbiotix Biotherapies, Inc. (“Symbiotix”), a pioneering microbiome company developing novel molecular therapeutics based on the human microbiome, today announced …See details»
Symbiotix Biotherapies, Inc. Employer Profile - MassBio Career …
Company Overview. Symbiotix Biotherapies, Inc. is venture-backed microbiome company founded on the basis of over two decades of research at Harvard Medical School/Brigham & …See details»
Symbiotix Biotherapies Announces Process Development
Jan 3, 2018 About Symbiotix Biotherapies, Inc. Symbiotix Biotherapies, Inc. is a pioneering venture-backed microbiome company founded on the basis of over two decades of research …See details»
Symbiotix Biotherapies Announces License Agreement with …
Mar 21, 2018 About Symbiotix Biotherapies, Inc. Symbiotix Biotherapies, Inc. is a pioneering venture-backed microbiome company founded on the basis of over two decades of research …See details»
Symbiotix Biotherapies Announces $2.3 Million Award from NIH's …
Jun 1, 2015 Symbiotix Biotherapies, Inc. was founded on the basis of over a decade of research at Brigham & Women's Hospital/ Harvard Medical School, California Institute of Technology …See details»
Symbiotix - Products, Competitors, Financials, Employees, …
Founded in 1998, Symbiotix is a specialized medical communications and marketing agency that works to leverage science through distinctive programming aimed at healthcare professionals …See details»
Agency 100 2020: Symbiotix - MM+M - Medical Marketing and …
Jun 8, 2020 Symbiotix was a well-regarded medical education and scientific communications shop with a nearly two-decades-long track record of solid programming. But in the four-plus …See details»
Symbiotix Company Profile 2024: Valuation, Investors ... - PitchBook
Symbiotix General Information Description. Provider of marketing and training services to the healthcare industry. The company offers brand planning, slide deck development, editorial …See details»
Why Symbiotix Medical Communications?
We are a specialized division focused on leveraging a synthesis of science, strategy, and creativity to spark change in healthcare behavior . We bring the intentional energy and focus of …See details»
Symbiotix Health | A Step Towards Better Human Health
Symbiotix is building a Health Data Marketplace using blockchain technology to ensure data provenance and ease of trade. Trust. Transparency. Compliance. Built on latest blockchain …See details»